Clinical Trial Update: ACCLAIM - Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial ACCLAIM evaluated immune modulation therapy for advanced chronic heart failure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Immune Modulation Therapy (Immunomodulation therapy)

Snippet

Sponsor: Vasogen | Conditions: Heart Failure, Congestive | Phase 3 | Status: COMPLETED